L3042

Levocabastine hydrochloride

≥99% (HPLC), solid

• Synonym(s): Levophta, Levostin, R50547, [3S-[1(cis),3α,4β]]-1-[4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenyl-4-piperidinecarboxylic acid
• Empirical Formula (Hill Notation): C₂₆H₂₉N₂O₂F·HCl
• CAS Number: 79547-78-7
• Molecular Weight: 456.98
• MDL number: MFCD07787408
• UNSPSC Code: 12352200
• PubChem Substance ID: 329817402

Properties

• Assay: ≥99% (HPLC)
• form: solid
• color: white
• solubility: DMSO: soluble ~10 mg/mL
• originator: Johnson & Johnson
• SMILES string: Cl[H].C[C@@H]1CN(CC[C@]1(C(O)=O)c2ccccc2)[C@@H]3CC[C@@](CC3)(C#N)c4ccc(F)cc4
• InChI: 1S/C26H29FN2O2.ClH/c1-19-17-29(16-15-26(19,24(30)31)21-5-3-2-4-6-21)23-11-13-25(18-28,14-12-23)20-7-9-22(27)10-8-20;/h2-10,19,23H,11-17H2,1H3,(H,30,31);1H/t19-,23-,25-,26-;/m1./s1
• InChI key: OICFWWJHIMKBCD-VALQNVSPSA-N
• Gene Information: human ... HRH1(3269)

Description

Biochem/physiol Actions

Non-peptide histamine H₁ receptor antagonist; neurotensin NTS₂ receptor ligand.

Features and Benefits

This compound is featured on the Neurotensin Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

This compound was developed by Johnson & Johnson. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Safety Information

• Pictograms: GHS07
• Signal Word: Warning
• Hazard Statements: H315,H319,H335
• Precautionary Statements: P261 - P264 - P271 - P280 - P302 + P352 - P305 + P351 + P338
• Hazard Classifications: Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
• Target Organs: Respiratory system
• Storage Class Code: 11 - Combustible Solids
• WGK: WGK 3
• Personal Protective Equipment: dust mask type N95 (US), Eyeshields, Gloves